Read more about ACB’s extensive work in GM and biosafety

Objection to Application by Dow for general release of GM maize: MON89034 X TC1507 x NK603 with the intention for cultivation in the entire region of South Africa

The ACB has played an essential watch-dog role on new GMO permits in South Africa for a decade now, adding substantially to the discourse about the scientific assessment of GMOs as well as about issues of socioeconomic impacts and democratic decisionmaking, through lodging substantive comments on at least 30 permit applications.

We are objecting to the general release of MON 89034 x TC1507 x NK603, due to concerns surrounding lack of safety to human and environmental health of this GM maize variety and its associated pesticides, glyphosate and glufosinate. This latest variety will serve to further increase exposure by the peoples of South Africa to yet more chemical pesticides, consolidate the corporate control of South Africa’s already corporatized food systems and entrench inequities and food insecurity.

ACB’s Objection to Monsanto’s Application for Commodity Clearance of MON 87708 × MON 89788 × A5547-127 Triple-Stacked Herbicide Tolerant Soybean

ACB is objecting to the commodity clearance of the triple-stacked GM soybean event MON 87708 x MON 89788 x A5547-127, due to concerns surrounding the lack of safety assessment data for this crop and the known toxicity of the three pesticides it is designed to tolerate.

Its tolerance to three pesticides, glyphosate, glufosinate and dicamba will only increase the exposure of South African citizens to ever increasing amounts of chemicals in their food systems, while South African regulators are yet to fully establish legal limits for these chemical on our crops.

Under these circumstances, we urge the Department of Agriculture, Forestry and Fisheries (DAFF) to decline approval until these safety uncertainties have been adequately addressed.